These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France. Laurent F, Tristan A, Croze M, Bes M, Meugnier H, Lina G, Vandenesch F, Etienne J. J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362 [No Abstract] [Full Text] [Related]
4. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections. Doudoulakakis A, Spiliopoulou I, Spyridis N, Giormezis N, Kopsidas J, Militsopoulou M, Lebessi E, Tsolia M. J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549 [Abstract] [Full Text] [Related]
5. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway. Rørtveit S, Skutlaberg DH, Langeland N, Rortveit G. Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166 [Abstract] [Full Text] [Related]
8. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). Elazhari M, Abu-Quatouseh LF, Elhabchi D, Zerouali K, Dersi N, Saile R, Timinouni M, Becker K. Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous. Liu Y, Kong F, Zhang X, Brown M, Ma L, Yang Y. Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868 [Abstract] [Full Text] [Related]
13. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. Woodford N, Afzal-Shah M, Warner M, Livermore DM. J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573 [Abstract] [Full Text] [Related]
14. The population structure of Staphylococcus aureus among general practice patients from The Netherlands. Donker GA, Deurenberg RH, Driessen C, Sebastian S, Nys S, Stobberingh EE. Clin Microbiol Infect; 2009 Feb; 15(2):137-43. PubMed ID: 19178545 [Abstract] [Full Text] [Related]
15. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008). Castanheira M, Watters AA, Mendes RE, Farrell DJ, Jones RN. J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787 [Abstract] [Full Text] [Related]
16. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. O'Neill AJ, Larsen AR, Henriksen AS, Chopra I. Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136 [Abstract] [Full Text] [Related]
19. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, Glupczynski Y, Malaviolle X, Vergison A, Struelens MJ. J Antimicrob Chemother; 2005 Dec; 56(6):1103-6. PubMed ID: 16223937 [Abstract] [Full Text] [Related]
20. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. Tveten Y, Jenkins A, Kristiansen BE. J Antimicrob Chemother; 2002 Dec; 50(6):873-6. PubMed ID: 12461006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]